Table 2.

IGF2 expression in LMP tumors and EOC

VariableLMP tumors (n = 36)EOC (n = 79)Total (n = 115)
IGF2 low, n (%)IGF2 high, n (%)PIGF2 low, n (%)IGF2 high, n (%)PIGF2 low, n (%)IGF2 high, n (%)P
Age (y)1.0000.8730.335
    ≤5017 (60.7)5 (62.5)9 (28.1)14 (29.8)26 (43.3)19 (34.5)
    >5011 (39.3)3 (37.5)23 (71.9)33 (70.2)34 (56.7)36 (65.5)
Race/ethnicity0.5440.3390.166
    Non-Hispanic White15 (53.6)6 (75.0)12 (37.5)24 (51.1)27 (45.0)30 (54.6)
    Hispanic10 (35.7)1 (12.5)14 (43.8)14 (29.8)24 (40.0)15 (27.3)
    American Indian1 (3.6)1 (12.5)5 (15.6)9 (19.1)6 (10.0)10 (18.2)
    Black1 (3.6)01 (3.1)02 (3.3)0
    Asian1 (3.6)0001 (1.7)0
FIGO stage0.0280.124<0.001
    I27 (96.4)5 (62.5)12 (37.5)12 (25.5)39 (65.0)17 (30.9)
    II02 (25.0)4 (12.5)3 (6.4)4 (6.7)5 (9.1)
    III1 (3.6)1 (12.5)15 (46.9)23 (48.9)16 (26.7)24 (43.6)
    IV001 (3.1)9 (19.1)1 (1.7)9 (16.4)
Histology0.0550.6640.011
    Serous10 (35.7)7 (87.5)17 (53.1)27 (57.4)27 (45.0)34 (61.8)
    Mucinous16 (57.1)1 (12.5)6 (18.8)5 (10.6)22 (36.7)6 (10.9)
    Endometrioid003 (9.4)3 (6.4)3 (5.0)3 (5.5)
    Other2 (7.1)06 (18.8)12 (25.5)8 (13.3)12 (21.8)
Tumor gradeN/A0.9330.003
    028 (100.0)8 (100.0)0028 (46.7)8 (14.6)
    1005 (15.6)7 (14.9)5 (8.3)7 (12.7)
    2007 (21.9)12 (25.5)7 (11.7)12 (21.8)
    30020 (62.5)28 (59.6)20 (33.3)28 (50.9)
Total28832476055

NOTE: IGF2 low, H-score ≤ 105; IGF2 high, H-score > 105.